Inotek Pharmaceuticals Announces the Completion of the Recruitment Phase of MATrX-1, the First Phase 3 Clinical Trial of Trabodenoson for Glaucoma

(Source: Yahoo Finance) Trabodenoson was developed in Inotek’s laboratories and is designed to restore the … The inclusion of our website address here and elsewhere in this press …